Nurse Practitioner in Jourdanton, TX Accepting Medicare

4 Nurse Practitioner nurses found. Showing 1 - 4

Danielle Stockhorst, FNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1907 Highway 97 E Ste 280, Jourdanton, TX 78026 Phone: 830-769-5912    Fax: 830-769-5913

Gina L Campbell, ANP-C Nurse Practitioner - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 1901 Highway 97 E, Suite 200, Jourdanton, TX 78026 Phone: 830-569-8147

Norma Jean Martinez, DNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 4355 N State Highway 16, Jourdanton, TX 78026 Phone: 210-367-5024

Tamara Rodriguez, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1907 Highway 97 E, Suite 280, Jourdanton, TX 78026 Phone: 830-769-5912    Fax: 830-769-5913

News Archive

EGS announces performance of 3,500th NOS procedure

EndoGastric Solutions (EGS), the leader in the emerging field of Natural Orifice Surgery (NOS), today reported that the 3,500th Natural Orifice Surgery (NOS) procedure was performed in front of the over 110 surgeons from seven countries attending the first Advanced Techniques in Transoral Fundoplication CME course, held January 28-29 in Denver, CO.

Colour-changing ABC Syringe shortlisted for 2014 World Design Impact Prize

University of Huddersfield lecturer Dr David Swann's design for a syringe that changes colour in order to deter its re-use - with the possibility of spreading dangerous infection - has already earned global interest. Now the project's profile will be raised higher still, following its shortlisting for a second major design award.

A program to reduce depression and isolation among the elderly during holiday season

MyWay Village, the first senior-focused technology company to help seniors get online in an easy and social way by combining access to simplified technology with personal training and support, today announced that their Connected Living program is reducing depression and feelings of isolation especially during the holiday season within senior communities where the company's programs are being offered.

Bayer receives priority review designation from FDA for regorafenib NDA

Bayer HealthCare and Onyx Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted priority review designation to Bayer HealthCare's New Drug Application (NDA) filed end of April 2012 for the oral multi-kinase inhibitor regorafenib, for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed after approved standard therapies.

Immune responses to airborne fungi could cause the stuffy noses and airway inflammation among sufferers of chronic rhinosinusitis

A team led by Mayo Clinic researchers has determined that over-reactive immune responses to airborne fungi could cause the stuffy noses and airway inflammation among sufferers of chronic rhinosinusitis.

Read more Medical News

› Verified 6 days ago